We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
House lawmakers have drafted legislation that would require
a new government study on the potential link between autism and the mercury-based vaccine preservative thimerosal.
HHS has bought six million additional doses of antiviral medication to be used in case of a pandemic flu outbreak, bringing to 26 million the total number of courses purchased.
In an effort to protect patients from counterfeit products, GlaxoSmithKline (GSK) has attached radio frequency identification (RFID) tags on all bottles of its HIV treatment Trizivir distributed in the U.S.
Despite the technological breakthroughs that have enhanced the R&D capabilities of pharmaceutical companies, drug research and development is facing a major problem as R&D productivity in the last decade is at a historical low despite recent innovations.
Swiss biotechnology company Serono, which has been the focus of takeover speculation for months, said Friday it planned to issue up to 7 billion Swiss francs ($5.4 billion) in new shares to increase capital and possibly fund its own acquisitions.
The Lubrizol Corporation announced today that it has agreed to sell its active pharmaceutical ingredient and intermediate compounds business, with facilities in Raubling, Germany and Chennai, India (A&I).
Cellegy Pharmaceuticals, Inc. announced its 2005 financial results today. Net loss for the years ended December 31, 2005 and 2004 were $5,007,639 ($.18 per share) and $28,154,062 ($1.28 per share), respectively, with revenues of $12,835,345 and $2,596,377, respectively.
Biosante Pharmaceuticals Inc. said it incurred a net loss of $9.7 million or $0.50 per share for the year ended December 31, 2005, compared to a net loss of $12 million or $0.70 per share in last year.
First Horizon Pharmaceutical Corporation today announced that it has been added to Standard and Poor's SmallCap 600 Global Industry Classification Standard (GICS(R)) Pharmaceuticals
Sub-Industry Index.